Article
Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease
Registro en:
ANDRADE, B. B. et al. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease. Plos One, v. 8, n. 5, p. e62618, 2013.
1932-6203
10.1371/journal.pone.0062618
Autor
Andrade, Bruno de Bezerril
Pavan Kumar, Nathella
Mayer-Barber, Katrin D
Barber, Daniel L
Sridhar, Rathinam
Rekha, Vaithilingam V Banu
Jawahar, Mohideen S
Nutman, Thomas B
Sher, Alan
Babu, Subash
Resumen
Andrade, Bruno Bezerril. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. Methods: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines
were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and
healthy controls as part of a prospective cohort study in South India.
Results: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary
tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively
discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid
protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but
not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited
significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-c and IL-17 and diminished levels of tumor necrosis
factor (TNF)-a.
Conclusion: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or
treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins